Cleared Traditional

K201250 - SQuEEZ Software

K201250 is the FDA 510(k) clearance for SQuEEZ Software by Cardiowise, Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 221-day FDA review.

K201250 · Cardiowise, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
221d
Days
Class 2
Risk

K201250 is an FDA 510(k) clearance for the SQuEEZ Software. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Cardiowise, Inc. (Fayetteville, US). The FDA issued a Cleared decision on December 18, 2020 after a review of 221 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Cardiowise, Inc. devices

Submission Details

510(k) Number K201250 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 11, 2020
Decision Date December 18, 2020
Days to Decision 221 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
114d slower than avg
Panel avg: 107d · This submission: 221d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Acknowledge Regulatory Strategies, LLC
Pierre Bounaud

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K201250.
ViewPoint 6
K203677 · GE Medical Systems Ultrasound & Primary Care Diagnostics, LLC · Jan 2021
BrainInsight
K202414 · Hyperfine Research, Inc. · Jan 2021
AI Metrics
K202229 · Ai Metrics, LLC · Dec 2020
HealthJOINT
K202487 · Zebra Medical Vision, Ltd. · Dec 2020
Nucleus.io
K203249 · Nucleushealth, LLC · Dec 2020
Planmeca Romexis
K200572 · Planmeca Oy · Dec 2020